Vita Life Sciences Limited

ASX:VLS.AX

2.3 (AUD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 74.16166.88657.10146.48142.45241.15137.73837.85838.58436.5835.41130.19124.26720.19117.01514.37611.87
Cost of Revenue 31.55727.14622.29317.20914.55513.5112.12211.711.4310.53811.36610.6748.5497.8586.7515.7925.059
Gross Profit 42.60439.7434.80829.27227.89727.64125.61626.15827.15426.04224.04519.51715.71812.33310.2648.5846.811
Gross Profit Ratio 0.5740.5940.610.630.6570.6720.6790.6910.7040.7120.6790.6460.6480.6110.6030.5970.574
Reseach & Development Expenses 0.0170.0040.0090.0080.0720.0150.0140.020.0160.0140.015000000
General & Administrative Expenses 18.05816.68714.65114.01214.66913.47511.77411.85812.89111.92311.87910.5119.1447.4725.8175.0484.419
Selling & Marketing Expenses 11.36610.4167.5656.1637.3756.7376.0936.1466.435.6215.0754.8483.8762.9092.5742.3771.751
SG&A 30.38927.10322.21620.17522.04420.21217.86718.00419.32117.54416.95415.35913.0210.3818.3917.4256.17
Other Expenses 0.1521.9181.5851.5521.746-1.7790.0010.2420.0370.171-0.0160.0810.0226.0010.1621.0360.504
Operating Expenses 30.38929.02123.80121.72723.7921.56520.9220.70721.07919.32518.48616.7314.2313.44110.4488.9697.228
Operating Income 12.21510.77211.3068.3244.5744.4294.8125.8056.267.0595.6522.9921.584.875-0.1550.4890.112
Operating Income Ratio 0.1650.1610.1980.1790.1080.1080.1280.1530.1620.1930.160.0990.0650.241-0.0090.0340.009
Total Other Income Expenses Net 0.236-0.034-0.105-0.166-0.146-1.7250.0020.2510.020.165-0.0480.0780.0016.0130.0760.850.397
Income Before Tax 12.45110.73811.2018.1584.4284.334.6765.6376.0026.9255.5162.8411.4034.626-0.3330.306-0.324
Income Before Tax Ratio 0.1680.1610.1960.1760.1040.1050.1240.1490.1560.1890.1560.0940.0580.229-0.020.021-0.027
Income Tax Expense 3.3733.3972.9542.2961.3341.8971.822.3011.651-0.3590.770.5250.190.167-0.005-0.048-0.12
Net Income 9.087.0848.2926.0943.1362.4392.8633.3434.3917.284.7482.3671.2134.46-0.3280.353-0.253
Net Income Ratio 0.1220.1060.1450.1310.0740.0590.0760.0880.1140.1990.1340.0780.050.221-0.0190.025-0.021
EPS 0.170.130.160.120.0570.0440.0520.0610.0790.130.0850.0440.0210.082-0.0070.007-0.01
EPS Diluted 0.170.130.160.120.0570.0440.0520.0590.0770.130.0840.0410.0210.082-0.0070.007-0.01
EBITDA 12.72711.37111.7158.8775.1784.8325.1496.0716.3747.1775.7653.0861.6734.993-0.0080.6510.246
EBITDA Ratio 0.1720.170.2050.1910.1220.1170.1360.160.1650.1960.1630.1020.0690.247-00.0450.021